New Yorkers Demand Transparency Before 340B Expansion

Advocates call for more oversight as state considers expanding drug discount program.

Apr. 10, 2026 at 8:42pm

Got story updates? Submit your updates here. ›

New York City's diverse communities, especially Hispanic neighborhoods, face some of the highest rates of chronic illness in the state and often bear a disproportionate share of healthcare costs. As the state considers expanding the 340B drug discount program, local advocates are calling for more transparency and oversight to ensure the benefits reach those who need it most.

Why it matters

The 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations at significantly reduced prices. However, there are concerns that the savings are not always passed on to patients. Expanding the program without proper safeguards could miss an opportunity to truly improve healthcare access in underserved communities.

The details

The 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations at significantly reduced prices. This includes hospitals that serve a disproportionate share of low-income patients. However, there are concerns that the savings are not always passed on to patients, with some healthcare providers using the discounts to boost their own bottom lines instead.

  • The New York state legislature is currently considering expanding the 340B program.

The players

New York City

The largest city in New York state, with diverse communities that face some of the highest rates of chronic illness and healthcare costs.

Hispanic communities

Neighborhoods in New York City that often carry a disproportionate share of healthcare costs and face high rates of chronic illness.

340B drug discount program

A federal program that requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations at significantly reduced prices.

Got photos? Submit your photos here. ›

What they’re saying

“The 340B program has the potential to improve healthcare access, but we need to ensure the savings are actually reaching patients in need, not just boosting provider profits.”

— Local healthcare advocate

What’s next

The New York state legislature will continue debating the proposed 340B expansion in the coming months, with advocates pushing for increased transparency and oversight.

The takeaway

As New York considers expanding the 340B program, there is a critical need for safeguards to ensure the benefits reach the diverse, underserved communities that face the greatest healthcare challenges.